Q-Line Biotech IPO
ListedQ-Line Biotech IPO Details
-
Bidding Date
21-May-2026 to
25-May-2026 -
Issue Size
₹214.48 Cr
-
Price Band
₹326 to ₹343
-
Allotment date
26-May-2026
-
Listing date
29-May-2026
-
Lot size
400
-
No. of shares
62,53,200
-
Fresh issue/OFS
₹214.48 Cr /--
About Q-Line Biotech Company
Q-Line Biotech was established in 2013 and has evolved from an import-led diagnostics business into an Indian manufacturer and distributor of in-vitro diagnostic solutions with a broader portfolio over time. Its core focus is on developing, manufacturing, marketing, and supplying reagents, consumables, rapid tests, IVD devices, and pathology equipment, with expertise spanning biochemistry, hematology, immunodiagnostics, molecular assays, lateral flow tests, ELISA, and point-of-care products. The company highlights strengths in indigenous product development, ISO-certified manufacturing, technology transfer for instrument production, and quality-focused after-sales support, while serving diagnostic service providers, hospitals, medical colleges, pathology labs, CROs, and other healthcare customers across India and export markets. Its operating approach emphasizes accessibility, affordability, and timely delivery, with an innovation-led mindset aimed at addressing regulatory, quality, and supply-chain demands in diagnostics.
Subscription Status
-
Category
Status
-
QIBs
--
-
NIIs
--
-
Retail
--
-
Others
--
-
Total
95.3x
FAQs for Q-Line Biotech IPO.
What is the issue size of Q-Line Biotech IPO?
The issue size of Q-Line Biotech is ₹214.48 Cr.
What is the industry of Q-Line Biotech?
Q-Line Biotech falls into Healthcare Devices & Equipment industry.
Where Q-Line Biotech IPO will be listed?
The Q-Line Biotech IPO will be listed on BSE.
What are the open and close dates for the Q-Line Biotech IPO?
The open and close dates for the Q-Line Biotech are 21-May-2026 & 25-May-2026.
What are the price band for Q-Line Biotech IPO?
The price band for the Q-Line Biotech ipo is ₹326 to ₹343
What is the listing date of Q-Line Biotech IPO?
The listing date of Q-Line Biotech IPO is 29-May-2026.
What is the purpose for the Q-Line Biotech IPO?
The purpose of this IPO is to raise fresh capital.
How much times Q-Line Biotech IPO subscribed?
Q-Line Biotech total subscription ratio is 95.3X.
What are the key financials for the Q-Line Biotech IPO?
Key financial of the Q-Line Biotech are:
| Q-Line Biotech | FY-25 | FY-24 | FY-23 |
|---|---|---|---|
| Revenue (₹ Cr) | 313.78 | 203.65 | 182.74 |
| EBIT (₹ Cr) | 67.17 | 34.13 | 31.61 |
| Proft after Tax (₹ Cr) | 24.51 | 21.64 | 21.38 |
| Debt (₹ Cr) | 166.29 | 96.91 | 73.65 |
| Net Worth (₹ Cr) | 189.95 | 161.81 | 127.37 |
| RoE (%) | 12.91 | 13.37 | 16.79 |